OBJECTIVE: To examine the longitudinal appearance of hippocampal (HC) damage in a prospective follow-up study of patients with newly diagnosed epilepsy. METHODS: A total of 103 patients with newly diagnosed focal epilepsy were scanned with MRI before antiepileptic medication was started. Serial MRI studies were scheduled after 1, 2 to 3, and 5 years of treatment in the ongoing follow-up study. Volumes of the HC were measured from MRI scans according to the Cavalieri method of modern design stereology and compared at different time points together with clinical variables. RESULTS: No difference was observed in the mean HC volumes between controls and patients at baseline, after 1, 2 to 3, and 5 years of follow-up. Individual analysis showed that 8% of patients had HC damage at the time of the diagnosis and 13% of patients developed HC volume decrease during 2 to 3 years of follow-up. These patients had longer duration of seizure disorder and larger seizure number before the epilepsy was diagnosed and treatment started compared with patients who did not show HC damage. CONCLUSIONS: Hippocampal volume decreases occur in individual patients with newly diagnosed focal epilepsy during the first years of treatment. The data obtained suggest that hippocampal volumetry provides a surrogate marker of the epileptic process.
OBJECTIVE: To examine the longitudinal appearance of hippocampal (HC) damage in a prospective follow-up study of patients with newly diagnosed epilepsy. METHODS: A total of 103 patients with newly diagnosed focal epilepsy were scanned with MRI before antiepileptic medication was started. Serial MRI studies were scheduled after 1, 2 to 3, and 5 years of treatment in the ongoing follow-up study. Volumes of the HC were measured from MRI scans according to the Cavalieri method of modern design stereology and compared at different time points together with clinical variables. RESULTS: No difference was observed in the mean HC volumes between controls and patients at baseline, after 1, 2 to 3, and 5 years of follow-up. Individual analysis showed that 8% of patients had HC damage at the time of the diagnosis and 13% of patients developed HC volume decrease during 2 to 3 years of follow-up. These patients had longer duration of seizure disorder and larger seizure number before the epilepsy was diagnosed and treatment started compared with patients who did not show HC damage. CONCLUSIONS: Hippocampal volume decreases occur in individual patients with newly diagnosed focal epilepsy during the first years of treatment. The data obtained suggest that hippocampal volumetry provides a surrogate marker of the epileptic process.
Authors: Simon Sean Keller; John Robin Highley; Marta Garcia-Finana; Vanessa Sluming; Roozbeh Rezaie; Neil Roberts Journal: J Anat Date: 2007-08-29 Impact factor: 2.610
Authors: Andrey Finegersh; Christina Avedissian; Sadat Shamim; Irene Dustin; Paul M Thompson; William H Theodore Journal: Epilepsia Date: 2011-01-26 Impact factor: 5.864
Authors: M T Acosta; J Munashinge; L Zhang; Daniel A Guerron; Alexander Vortmeyer; W H Theodore Journal: Acta Neurol Scand Date: 2011-05-26 Impact factor: 3.209
Authors: Braxton A Norwood; Argyle V Bumanglag; Francesco Osculati; Andrea Sbarbati; Pasquina Marzola; Elena Nicolato; Paolo F Fabene; Robert S Sloviter Journal: J Comp Neurol Date: 2010-08-15 Impact factor: 3.215
Authors: Angelo Labate; Antonio Gambardella; Eva Andermann; Umberto Aguglia; Fernando Cendes; Samuel F Berkovic; Frederick Andermann Journal: Nat Rev Neurol Date: 2011-01-25 Impact factor: 42.937
Authors: Céline M Dubé; Teresa Ravizza; Mark Hamamura; Qinqin Zha; Andrew Keebaugh; Kimberly Fok; Adrienne L Andres; Orhan Nalcioglu; Andre Obenaus; Annamaria Vezzani; Tallie Z Baram Journal: J Neurosci Date: 2010-06-02 Impact factor: 6.167
Authors: Anna W Byars; Ton J deGrauw; Cynthia S Johnson; Philip S Fastenau; Susan M Perkins; John C Egelhoff; Andrew Kalnin; David W Dunn; Joan K Austin Journal: Epilepsia Date: 2007-04-18 Impact factor: 5.864
Authors: Andrew J Kalnin; Philip S Fastenau; Ton J deGrauw; Beverly S Musick; Susan M Perkins; Cynthia S Johnson; Vincent P Mathews; John C Egelhoff; David W Dunn; Joan K Austin Journal: Pediatr Neurol Date: 2008-12 Impact factor: 3.372